Shanghai Kaibao 8.5 million yuan to introduce "Huadan Anshen mixture" new drug technology and patent right
-
Last Update: 2020-04-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Shanghai Kaibao Pharmaceutical Co., Ltd announced in the evening of January 13, 2014 that the company recently used its own funds of 8.5 million yuan to purchase new drug technology and patent rights of "Huadan Anshen mixture" project Huadan Anshen mixture is a kind of traditional Chinese medicine composition, preparation method and application with the function of calming liver, promoting blood circulation and tranquilizing mind According to the company, "Huadan Anshen mixture" is consistent with the strategic R & D direction of the company's new drug reserve, which is conducive to the company to solve the problem of single products, enrich the company's future product echelon, and is necessary for the company's long-term development Wang Qiaochu (1927 -) He has successively served as the director of the second joint clinic of Xuhui District, the resident surgeon of the branch of Shanghai Sixth People's Hospital, the chief physician of traditional Chinese medicine, the deputy director, deputy director and deputy chief physician of the scientific research department and the traditional Chinese Medicine Department of Shanghai Municipal Health Bureau, the investigator, the director and chief physician of the Shanghai Traditional Chinese medicine literature museum, the director of the Shanghai Institute of traditional Chinese medicine information, and the Shanghai staff medical college Professor, member of traditional Chinese medicine professional group of Shanghai senior Title Evaluation Committee, member of basic theory evaluation of scientific research achievements of State Administration of traditional Chinese medicine, vice president of National Acupuncture and Anesthesia Research Association, Deputy Secretary General of Shanghai Society of traditional Chinese medicine, executive director of Shanghai Society of integrated traditional Chinese and Western medicine, executive Editorial Committee of Shanghai Journal of traditional Chinese medicine, Shanghai Journal of acupuncture and moxibustion, expert consultant of Shanghai Hospital of traditional Chinese Medicine Deputy director of the committee, director of the sleep Disease Research Office of traditional Chinese medicine, director of Shanghai Medical Cooperation Center of insomnia of traditional Chinese medicine (now Shanghai specialty of insomnia of traditional Chinese Medicine), part-time professor of Shanghai University of traditional Chinese medicine, awarded as Shanghai famous traditional Chinese medicine in 1995; approved by the first Bureau of the second Ministry of the state from 1996 to 2002 as the second and third group of old traditional Chinese medicine inherited class instructor In December 2006, Shanghai Municipal Health Bureau, Human Resources Bureau and science and Technology Commission approved to be the doctoral teaching teacher of Shanghai Shicheng class Scientific research consultant of traditional Chinese Medicine Department of Shanghai Health Bureau At present, he is the director of sleep disease advantage specialty of Shanghai Hospital of traditional Chinese medicine, director of Wang Qiaochu old traditional Chinese medicine studio, professor for life, honorary director of sleep Disease Research Institute of traditional Chinese medicine, member of the academic committee of Revitalizing Traditional Chinese medicine of Shanghai Health Bureau, and consultant of Shanghai Science and technology service center of traditional Chinese medicine Consultant of the Council of China sleep research association and honorary director of the professional committee of sleep medicine of traditional Chinese medicine From 1995 to December 1997, "study on the extraction and separation of effective parts and pharmacodynamics of peanut leaves in the treatment of insomnia" was listed as a shortlisted project by the State Administration of traditional Chinese medicine At the same time, it was listed as a key project by Shanghai Science and Technology Commission and completed and identified in the first half of 1999 In May 1999, in the bidding project of new drug development office of Shanghai Municipal Science and Technology Commission, "extraction and separation of effective parts of peanut leaf for insomnia and pharmacodynamics research" won the bid, and was listed as the clinical verification project of new drug development office of Shanghai, with a funding of 150000 yuan In May 2000, 146 cases of clinical verification and observation of "891" Anshen mixture II were completed ahead of schedule and over fulfilled as planned, and the blindness was uncovered through the acceptance of experts organized by the Municipal Science and Technology Commission in time The clinical efficacy of peanut leaf in the treatment of insomnia and related pharmaceutical research won the third prize of science and technology progress of Shanghai Municipal People's Government in 2001 The preparation and preparation method of peanut leaf extract obtained the patent certificate of the people's Republic of China and the international patent application number In July 2000, the new drug Office of the Municipal Science and Technology Commission invited bids, and the pre clinical study of Huadan Anshen mixture in the treatment of insomnia was reviewed and approved by experts It was listed as the new drug development risk fund project of the Municipal Science and Technology Commission, and the cooperation funding of the Municipal Science and Technology Commission and the Health Bureau was 700000 yuan (including 150000 yuan of the Municipal Health Bureau) It passed the result appraisal on June 19, 2003 On September 2, 2004, Huadan Anshen mixture was approved by the State Food and drug administration, and obtained the approval document of drug clinical research In June 2002, the single disease project of Shanghai Municipal Bureau of health, the research on the standardization of clinical diagnosis and treatment standards of Chinese medicine for insomnia, was completed in December 2003, and the research project of the hospital level project, the clinical diagnosis and treatment program of Chinese medicine insomnia specialty in Shanghai, was also completed In October 2003, the clinical comparative study of Huadan Anshen mixture in the treatment of insomnia was listed as the youth fund project of Shanghai Health Bureau, which is currently under implementation In 2004, the preparation and preparation method of peanut leaf extract was patented The pre clinical study of Huadan Anshen mixture in the treatment of insomnia was awarded the scientific and technological achievement certificate of Shanghai in 2004
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.